Lacktman Comments on New Connecticut Law Allowing Telemedicine Prescriptions
27 June 2018
mHealthIntelligence
Partner Nate Lacktman was quoted in an mHealthIntelligence article, “New Connecticut Law Enables Providers to Prescribe Via Telemedicine,” about the passage of a law that allows health care providers to use telemedicine to prescribe certain controlled substances for mental health and substance abuse treatment.
Lacktman said the new law is a “huge benefit” for Connecticut patients with mental health or substance abuse issues, and “follows a growing trend among states to amend and eliminate prior statutory prohibitions on telemedicine prescribing of controlled substances, particularly in light of the goal of supporting the availability of alternative therapies to address the opioid crisis.”
Lacktman said the new law is a “huge benefit” for Connecticut patients with mental health or substance abuse issues, and “follows a growing trend among states to amend and eliminate prior statutory prohibitions on telemedicine prescribing of controlled substances, particularly in light of the goal of supporting the availability of alternative therapies to address the opioid crisis.”
People
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"